181 related articles for article (PubMed ID: 10479523)
1. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
Hoffman JS; Laird L; Benadiva C; Dreiss R
Gynecol Oncol; 1999 Sep; 74(3):515-8. PubMed ID: 10479523
[TBL] [Abstract][Full Text] [Related]
2. Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report.
Miller DM; Ehlen TG; Saleh EA
Gynecol Oncol; 1997 Sep; 66(3):535-8. PubMed ID: 9299273
[TBL] [Abstract][Full Text] [Related]
3. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
4. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
6. Surgery in advanced borderline tumors.
Viganò R; Petrone M; Pella F; Rabaiotti E; De Marzi P; Mangili G
Fertil Steril; 2010 Aug; 94(3):1163-5. PubMed ID: 20036359
[TBL] [Abstract][Full Text] [Related]
7. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
10. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
Kadar N; Krumerman M
Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
[TBL] [Abstract][Full Text] [Related]
11. Successful pregnancy after conservative surgery for stage IC ovarian cancer with serous borderline tumor on controlateral ovary: a case report.
Battaglia F; Plotti F; Zullo MA; Panici PB; Plotti G
Gynecol Oncol; 2006 Mar; 100(3):612-4. PubMed ID: 16249017
[TBL] [Abstract][Full Text] [Related]
12. [Ovarian serous borderline tumor: the prognostic relation to the pathologic features and management].
Zhou XR; Du XG
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):601-3, 637. PubMed ID: 7712874
[TBL] [Abstract][Full Text] [Related]
13. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian low malignant potential tumor: how to preserve fertility?].
Koskas M; Madelenat P; Yazbeck C
Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
[TBL] [Abstract][Full Text] [Related]
15. [Conservative management of malignant and borderline ovarian tumor].
Morice P; Camatte S; Wickart-Poque F; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Bull Cancer; 2002 Dec; 89(12):1019-26. PubMed ID: 12525360
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
[TBL] [Abstract][Full Text] [Related]
17. Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
Allison KH; Swisher EM; Kerkering KM; Garcia RL
Int J Gynecol Pathol; 2008 Jan; 27(1):10-7. PubMed ID: 18156968
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
[TBL] [Abstract][Full Text] [Related]
20. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
